SYNTHETIC LETHALITY IN P53 MUTATED B-CELL MALIGNANCIES: CHK-1 INHIBITION AND DNA-PK INHIBITION EFFECT IN CELL LINES AND PRIMARY CLL CELLS

被引：0
|
作者：
Zemanova, J. [1 ]
Sebejova, L. [1 ]
Paruch, K. [2 ]
Hylse, O. [2 ]
Pospisilova, S. [1 ]
Mayer, J. [3 ]
Trbusek, M. [1 ]
机构：
[1] FN St Anna, Cent European Inst Technol MU, Brno, Czech Republic
[2] FN St Anna, Int Clin Res Ctr, Brno, Czech Republic
[3] FN Brno, Dept Internal Med, Brno, Czech Republic
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P971
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [21] Can the P53 status predict the outcome of Polo-like kinase 1 inhibition in non-small cell lung cancer cell lines?
    Van den Bossche, J.
    Wouters, A.
    Deben, C.
    Deschoolmeester, V.
    Specenier, P.
    Pauwels, P.
    Peeters, M.
    Lardon, F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 27 - 27
  • [22] Inhibition of SIRT1/p53 pathway by miR-211 and induction of cell death in breast cancer cells
    Nourbakhsh, M.
    Yarahmadi, S.
    Abdolvahabi, Z.
    Hesari, Z.
    Tavakoli-Yaraki, M.
    Yousefi, Z.
    Seiri, P.
    FEBS OPEN BIO, 2019, 9 : 244 - 245
  • [23] Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia
    Lee, Tet Woo
    Wong, Way Wua
    Dickson, Benjamin D.
    Lipert, Barbara
    Cheng, Gary J.
    Hunter, Francis W.
    Hay, Michael P.
    Wilson, William R.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2019, 95 (12) : 1597 - 1612
  • [24] Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage
    Solomon, JM
    Pasupuleti, R
    Xu, L
    McDonagh, T
    Curtis, R
    DiStefano, PS
    Huber, LJ
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (01) : 28 - 38
  • [25] Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells
    Smith, Paul J.
    Marquez, Nuria
    Wiltshire, Marie
    Chappell, Sally
    Njoh, Kerenza
    Campbell, Lee
    Khan, Imtiaz A.
    Silvestre, Oscar
    Errington, Rachel J.
    CELL CYCLE, 2007, 6 (16) : 2071 - 2081
  • [26] Aberrations of the CDKN2A network components p16, p53 and RB1 in primary cutaneous B-cell lymphoma
    Kaune, K.
    Hallermann, C.
    Haller, F.
    Schoen, M. P.
    Neumann, C.
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (03) : 317 - 317
  • [27] Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cells
    Ebrahimi, Elham
    Shabestari, Rima Manafi
    Bashash, Davood
    Safa, Majid
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2025 - 2036
  • [28] Synergistic apoptotic effect of Mcl-1 inhibition and doxorubicin on B-cell precursor acute lymphoblastic leukemia cells
    Elham Ebrahimi
    Rima Manafi Shabestari
    Davood Bashash
    Majid Safa
    Molecular Biology Reports, 2022, 49 : 2025 - 2036
  • [29] UCN-O1: A promising new agent for B-cell chronic lymphocytic leukemia (B-CLL) that induces apoptosis independent of p53 status.
    Byrd, JC
    Shinn, CA
    Bedi, A
    Waselenko, JK
    Flinn, IW
    Diehl, LF
    Sausville, E
    Grever, MR
    BLOOD, 1997, 90 (10) : 4125 - 4125
  • [30] PI3K/AKT Mediated P53 Down-Regulation Participates in CpG DNA Inhibition of Spontaneous B Cell Apoptosis
    Yongxin Zhou
    Huiling Zhen
    Yunqing Mei
    Yongwu Wang
    Jing Feng
    Shuchang Xu
    Xiaoying Fu
    Cellular & Molecular Immunology, 2009, 6 : 175 - 180
12345